

Marvin Founders Q3 Virtual Showcase
Back for our third showcase of the year. Q1 and Q2 set the bar, Q3 raises it.
Every quarter we put a handful of early-stage founders in front of a room of investors, McKinsey alumni, and fellow founders. Live pitches, real feedback, and the kind of connections that keep going after the night ends.
Founders Pitching:
Kismet by Jason Cincotta
"Kismet is booking infrastructure for the agentic era. We make lodging catalogs operable by AI agents, so guests book direct with the brand instead of through an OTA."
KanopyAI by Yann Pfitzer
"KanopyAI turns video into a living 3D model of the power grid, so operators can run maintenance from real-time data."
"Cardiac recovery and resilience intelligence platform combining digital health with recovery science."
“The AI Operating System for Transplant Teams.”
Roz by Donnie Hampton
“Roz is building the agentic execution layer for audit. We automate control testing and evidence review for assurance firms, risk advisory practices, and internal audit teams, eliminating up to 80% of manual fieldwork and fundamentally changing the labor economics of audit.”
HAI Educators by Geraldine Medina
“Redefining Educator Preparation for the AI Era.”
Stealth by Alizeh Gangi
“A new category—Grief Care—for the 300M+ people who lose someone every year: emotional, practical, and social support in one place.”
"Crop protection for a changing world."
PhotonicDx by Tim Gustafson
"Ultrasensitive molecular detection made fast, affordable, and scalable."
HolaVida by Eric Macias
"HolaVida Health is an AI-native healthcare infrastructure platform redefining how care is accessed and delivered for patients in the United States."
OliMed by Tanush Jagdish
"OliMed is the AI chief of staff for independent medical practices. It answers the phones, keeps the schedule full, and recovers revenue lost to prior authorizations, denied claims, and underpayments."
Heureka by Ion Bolohan
"Heureka Labs is an AI research platform and autonomous engine powering better, faster, lower cost, more secure, and customized insights for biomedical discovery."